MGTX News and Press, MeiraGTx Holdings plc From 05/07/20

MeiraGTx (NASDAQ: MGTX ): Q1 GAAP EPS of -$0.43 in-line. More news on: MeiraGTx Holdings plc, Earnings news and commentary, Healthcare stocks news, Read more ...

LONDON and NEW YORK, May 07, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced financial results for the first quarter ended March 31, 2020 and provided an update on recent progress. ...

LONDON and NEW YORK, May 06, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph.D., president and chief executive officer, will present at the Virtua...

Introduction The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than 5 years. This subset of the different portfolios I regularly analyze has now reached 153 weeks of public selections as part of this ongoing live forward-testing resea...

Today, we will see why MeiraGTx ( MGTX ) is an enticing gene therapy pick in March 2020. Company overview MeiraGTx is a vertically-integrated, clinical-stage gene therapy company focused on developing novel and cost-effective treatments for diseases with significant unmet demand. Founded...

The following slide deck was published by MeiraGTx Holdings plc in conjunction with this Read more ...

Today, we will see why Kadmon Holdings ( KDMN ) is an attractive pick in March 2020. Company overview Founded in 2009, Kadmon Holdings went public in 2016. The company is a late-stage biopharmaceutical company focused on the development and commercialization of small molecule therapies a...

MeiraGTx (NASDAQ: MGTX ): FY GAAP EPS of -$1.65 beats by $0.45 . More news on: MeiraGTx Holdings plc, Earnings news and commentary, Healthcare stocks news, Read more ...

LONDON and NEW YORK, March 11, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced financial results for the full year ended December 31, 2019 and provided an update on recent progress. ...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...